April 17, 2020 / Kelsy Ketchum Abbott Laboratories wants to ramp up production to at least 5 million tests in April, including COVID-19 diagnostic and serology tests, the company said on a first quarter earnings call on Thursday. The company committed to manufacturing 50,000 rapid point-of-care diagnostic tests per day beginning in April, and according to President and CEO …

Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone